BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25690042)

  • 21. JAK-STAT signaling pathways are activated in the brain following reovirus infection.
    Goody RJ; Beckham JD; Rubtsova K; Tyler KL
    J Neurovirol; 2007 Aug; 13(4):373-83. PubMed ID: 17849321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin-3-gallate sensitizes IFN-γ-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1.
    Wu X; Shao F; Yang Y; Gu L; Zheng W; Wu X; Gu Y; Shu Y; Sun Y; Xu Q
    Int Immunopharmacol; 2014 Dec; 23(2):434-41. PubMed ID: 25261409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-inhibition of interferon-induced signals by GM-CSF through a block in Stat1 activation.
    Kasper S; Kindler T; Sonnenschein S; Breitenbuecher F; Böhmer FD; Huber C; Fischer T
    J Interferon Cytokine Res; 2007 Nov; 27(11):947-59. PubMed ID: 18052729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Watanabe S
    Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma.
    Carson WE
    Clin Cancer Res; 1998 Sep; 4(9):2219-28. PubMed ID: 9748142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNFα suppresses IFNγ-induced MHC class II expression on retinal pigmented epithelial cells cultures.
    Makhoul M; Bruyns C; Edimo WE; Relvas LJ; Bazewicz M; Koch P; Caspers L; Willermain F
    Acta Ophthalmol; 2012 Feb; 90(1):e38-42. PubMed ID: 21957872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation.
    Klampfer L; Huang J; Kaler P; Sasazuki T; Shirasawa S; Augenlicht L
    Oncogene; 2007 Mar; 26(14):2071-81. PubMed ID: 17016440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
    Lynch RA; Etchin J; Battle TE; Frank DA
    Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
    Respa A; Bukur J; Ferrone S; Pawelec G; Zhao Y; Wang E; Marincola FM; Seliger B
    Clin Cancer Res; 2011 May; 17(9):2668-78. PubMed ID: 21248298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TWEAK signals through JAK-STAT to induce tumor cell apoptosis.
    Chapman MS; Wu L; Amatucci A; Ho SN; Michaelson JS
    Cytokine; 2013 Jan; 61(1):210-7. PubMed ID: 23107828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling.
    Bozeman R; Abel EL; Macias E; Cheng T; Beltran L; DiGiovanni J
    Mol Carcinog; 2015 Aug; 54(8):642-53. PubMed ID: 24464587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells.
    Wang Y; Ren Z; Tao D; Tilwalli S; Goswami R; Balabanov R
    Glia; 2010 Jan; 58(2):195-208. PubMed ID: 19606498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression.
    Panek RB; Lee YJ; Benveniste EN
    J Immunol; 1995 Jan; 154(2):610-9. PubMed ID: 7814871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histamine inhibits the production of interferon-induced protein of 10 kDa in human squamous cell carcinoma and melanoma.
    Kanda N; Watanabe S
    J Invest Dermatol; 2002 Dec; 119(6):1411-9. PubMed ID: 12485448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marek's disease virus influences the expression of genes associated with IFN-gamma-inducible MHC class II expression.
    Thanthrige-Don N; Read LR; Abdul-Careem MF; Mohammadi H; Mallick AI; Sharif S
    Viral Immunol; 2010 Apr; 23(2):227-32. PubMed ID: 20374003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orf virus inhibits interferon stimulated gene expression and modulates the JAK/STAT signalling pathway.
    Harvey R; McCaughan C; Wise LM; Mercer AA; Fleming SB
    Virus Res; 2015 Oct; 208():180-8. PubMed ID: 26113305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor.
    Hussain S; Zwilling BS; Lafuse WP
    J Immunol; 1999 Aug; 163(4):2041-8. PubMed ID: 10438942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
    Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.